JPS6150960B2 - - Google Patents
Info
- Publication number
- JPS6150960B2 JPS6150960B2 JP52020399A JP2039977A JPS6150960B2 JP S6150960 B2 JPS6150960 B2 JP S6150960B2 JP 52020399 A JP52020399 A JP 52020399A JP 2039977 A JP2039977 A JP 2039977A JP S6150960 B2 JPS6150960 B2 JP S6150960B2
- Authority
- JP
- Japan
- Prior art keywords
- compound
- atom
- methyl
- diene
- chlorine atom
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 150000001875 compounds Chemical class 0.000 claims description 61
- 229910052801 chlorine Inorganic materials 0.000 claims description 20
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 18
- 239000003795 chemical substances by application Substances 0.000 claims description 13
- -1 isonicotinoyl group Chemical group 0.000 claims description 13
- 238000000034 method Methods 0.000 claims description 13
- 239000000203 mixture Substances 0.000 claims description 13
- 125000002252 acyl group Chemical group 0.000 claims description 9
- 125000004432 carbon atom Chemical group C* 0.000 claims description 7
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 7
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 6
- 229910052731 fluorine Inorganic materials 0.000 claims description 6
- 125000001153 fluoro group Chemical group F* 0.000 claims description 6
- 230000003110 anti-inflammatory effect Effects 0.000 claims description 5
- 125000005843 halogen group Chemical group 0.000 claims description 5
- 230000002140 halogenating effect Effects 0.000 claims description 5
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 claims description 4
- KZNICNPSHKQLFF-UHFFFAOYSA-N succinimide Chemical compound O=C1CCC(=O)N1 KZNICNPSHKQLFF-UHFFFAOYSA-N 0.000 claims description 4
- 239000003153 chemical reaction reagent Substances 0.000 claims description 3
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims description 2
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 125000001325 propanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 claims description 2
- 229960002317 succinimide Drugs 0.000 claims description 2
- 125000003774 valeryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 15
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 10
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 8
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 8
- 239000002253 acid Substances 0.000 description 8
- 229960003957 dexamethasone Drugs 0.000 description 8
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 8
- 238000003756 stirring Methods 0.000 description 8
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 206010018691 Granuloma Diseases 0.000 description 6
- 206010030113 Oedema Diseases 0.000 description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 6
- 238000002844 melting Methods 0.000 description 6
- 230000008018 melting Effects 0.000 description 6
- 230000000699 topical effect Effects 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 5
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 239000011541 reaction mixture Substances 0.000 description 5
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 5
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 239000002671 adjuvant Substances 0.000 description 4
- 239000012043 crude product Substances 0.000 description 4
- 239000005457 ice water Substances 0.000 description 4
- TWBYWOBDOCUKOW-UHFFFAOYSA-N isonicotinic acid Chemical compound OC(=O)C1=CC=NC=C1 TWBYWOBDOCUKOW-UHFFFAOYSA-N 0.000 description 4
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
- 239000002674 ointment Substances 0.000 description 4
- 239000008194 pharmaceutical composition Substances 0.000 description 4
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 4
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- JRNVZBWKYDBUCA-UHFFFAOYSA-N N-chlorosuccinimide Chemical compound ClN1C(=O)CCC1=O JRNVZBWKYDBUCA-UHFFFAOYSA-N 0.000 description 3
- 150000007513 acids Chemical class 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- ZOJBYZNEUISWFT-UHFFFAOYSA-N allyl isothiocyanate Chemical compound C=CCN=C=S ZOJBYZNEUISWFT-UHFFFAOYSA-N 0.000 description 3
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 3
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 3
- 239000008164 mustard oil Substances 0.000 description 3
- 239000008188 pellet Substances 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 239000000377 silicon dioxide Substances 0.000 description 3
- 210000001541 thymus gland Anatomy 0.000 description 3
- KEXFRBIOHPDZQM-UHFFFAOYSA-N 1,1-bis(2,2-dimethylpropoxy)-n,n-dimethylmethanamine Chemical compound CC(C)(C)COC(N(C)C)OCC(C)(C)C KEXFRBIOHPDZQM-UHFFFAOYSA-N 0.000 description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 229940126062 Compound A Drugs 0.000 description 2
- 229920000742 Cotton Polymers 0.000 description 2
- KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 2
- NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 239000004166 Lanolin Substances 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 239000004264 Petrolatum Substances 0.000 description 2
- RTEXIPZMMDUXMR-UHFFFAOYSA-N benzene;ethyl acetate Chemical compound CCOC(C)=O.C1=CC=CC=C1 RTEXIPZMMDUXMR-UHFFFAOYSA-N 0.000 description 2
- MDHYEMXUFSJLGV-UHFFFAOYSA-N beta-phenethyl acetate Natural products CC(=O)OCCC1=CC=CC=C1 MDHYEMXUFSJLGV-UHFFFAOYSA-N 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- NZNMSOFKMUBTKW-UHFFFAOYSA-N cyclohexanecarboxylic acid Chemical compound OC(=O)C1CCCCC1 NZNMSOFKMUBTKW-UHFFFAOYSA-N 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 210000005069 ears Anatomy 0.000 description 2
- 235000019253 formic acid Nutrition 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- KQNPFQTWMSNSAP-UHFFFAOYSA-N isobutyric acid Chemical compound CC(C)C(O)=O KQNPFQTWMSNSAP-UHFFFAOYSA-N 0.000 description 2
- 229940039717 lanolin Drugs 0.000 description 2
- 235000019388 lanolin Nutrition 0.000 description 2
- 229910052744 lithium Inorganic materials 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 229940066842 petrolatum Drugs 0.000 description 2
- 235000019271 petrolatum Nutrition 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 238000007127 saponification reaction Methods 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Inorganic materials [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 2
- 230000003096 thymolvtic effect Effects 0.000 description 2
- ZDPHROOEEOARMN-UHFFFAOYSA-N undecanoic acid Chemical compound CCCCCCCCCCC(O)=O ZDPHROOEEOARMN-UHFFFAOYSA-N 0.000 description 2
- 238000003828 vacuum filtration Methods 0.000 description 2
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- FUFLCEKSBBHCMO-UHFFFAOYSA-N 11-dehydrocorticosterone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 FUFLCEKSBBHCMO-UHFFFAOYSA-N 0.000 description 1
- WZJZMVSJWUHDOB-UHFFFAOYSA-N 3-chloropyrrolidine-2,5-dione Chemical compound ClC1CC(=O)NC1=O WZJZMVSJWUHDOB-UHFFFAOYSA-N 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- MFYSYFVPBJMHGN-ZPOLXVRWSA-N Cortisone Chemical compound O=C1CC[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 MFYSYFVPBJMHGN-ZPOLXVRWSA-N 0.000 description 1
- MFYSYFVPBJMHGN-UHFFFAOYSA-N Cortisone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)(O)C(=O)CO)C4C3CCC2=C1 MFYSYFVPBJMHGN-UHFFFAOYSA-N 0.000 description 1
- YYLLIJHXUHJATK-UHFFFAOYSA-N Cyclohexyl acetate Chemical compound CC(=O)OC1CCCCC1 YYLLIJHXUHJATK-UHFFFAOYSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 241000700157 Rattus norvegicus Species 0.000 description 1
- 206010041303 Solar dermatitis Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- SIKHQNIGPLUJDX-ZEQQQVMLSA-N [2-[(8s,9s,10r,13s,14s,17s)-10,13-dimethyl-3-oxo-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] propanoate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)COC(=O)CC)[C@@]1(C)CC2 SIKHQNIGPLUJDX-ZEQQQVMLSA-N 0.000 description 1
- 150000008065 acid anhydrides Chemical class 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- HOPRXXXSABQWAV-UHFFFAOYSA-N anhydrous collidine Natural products CC1=CC=NC(C)=C1C HOPRXXXSABQWAV-UHFFFAOYSA-N 0.000 description 1
- 239000008135 aqueous vehicle Substances 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- WORJEOGGNQDSOE-UHFFFAOYSA-N chloroform;methanol Chemical compound OC.ClC(Cl)Cl WORJEOGGNQDSOE-UHFFFAOYSA-N 0.000 description 1
- UTBIMNXEDGNJFE-UHFFFAOYSA-N collidine Natural products CC1=CC=C(C)C(C)=N1 UTBIMNXEDGNJFE-UHFFFAOYSA-N 0.000 description 1
- JNGZXGGOCLZBFB-IVCQMTBJSA-N compound E Chemical compound N([C@@H](C)C(=O)N[C@@H]1C(N(C)C2=CC=CC=C2C(C=2C=CC=CC=2)=N1)=O)C(=O)CC1=CC(F)=CC(F)=C1 JNGZXGGOCLZBFB-IVCQMTBJSA-N 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 229960004544 cortisone Drugs 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- HJZLEGIHUQOJBA-UHFFFAOYSA-N cyclohexane propionic acid Chemical compound OC(=O)CCC1CCCCC1 HJZLEGIHUQOJBA-UHFFFAOYSA-N 0.000 description 1
- JBDSSBMEKXHSJF-UHFFFAOYSA-N cyclopentane carboxylic acid Natural products OC(=O)C1CCCC1 JBDSSBMEKXHSJF-UHFFFAOYSA-N 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- QTLXOODKFXNGOZ-UHFFFAOYSA-N dichloromethane;methanol;2-propan-2-yloxypropane Chemical compound OC.ClCCl.CC(C)OC(C)C QTLXOODKFXNGOZ-UHFFFAOYSA-N 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- VBTQNRFWXBXZQR-UHFFFAOYSA-N n-bromoacetamide Chemical compound CC(=O)NBr VBTQNRFWXBXZQR-UHFFFAOYSA-N 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- 239000002687 nonaqueous vehicle Substances 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- DUCKXCGALKOSJF-UHFFFAOYSA-N pentanoyl pentanoate Chemical compound CCCCC(=O)OC(=O)CCCC DUCKXCGALKOSJF-UHFFFAOYSA-N 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 229940068968 polysorbate 80 Drugs 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- WYVAMUWZEOHJOQ-UHFFFAOYSA-N propionic anhydride Chemical compound CCC(=O)OC(=O)CC WYVAMUWZEOHJOQ-UHFFFAOYSA-N 0.000 description 1
- LVTJOONKWUXEFR-FZRMHRINSA-N protoneodioscin Natural products O(C[C@@H](CC[C@]1(O)[C@H](C)[C@@H]2[C@]3(C)[C@H]([C@H]4[C@@H]([C@]5(C)C(=CC4)C[C@@H](O[C@@H]4[C@H](O[C@H]6[C@@H](O)[C@@H](O)[C@@H](O)[C@H](C)O6)[C@@H](O)[C@H](O[C@H]6[C@@H](O)[C@@H](O)[C@@H](O)[C@H](C)O6)[C@H](CO)O4)CC5)CC3)C[C@@H]2O1)C)[C@H]1[C@H](O)[C@H](O)[C@H](O)[C@@H](CO)O1 LVTJOONKWUXEFR-FZRMHRINSA-N 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- ODZPKZBBUMBTMG-UHFFFAOYSA-N sodium amide Chemical compound [NH2-].[Na+] ODZPKZBBUMBTMG-UHFFFAOYSA-N 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- GFYHSKONPJXCDE-UHFFFAOYSA-N sym-collidine Natural products CC1=CN=C(C)C(C)=C1 GFYHSKONPJXCDE-UHFFFAOYSA-N 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 230000002992 thymic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 229940005605 valeric acid Drugs 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0007—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa
- C07J5/0023—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa substituted in position 16
- C07J5/003—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group including 16-alkylidene substitutes
- C07J5/0038—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group including 16-alkylidene substitutes by an alkyl group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Description
æ¬çºæã®äž»é¡ã¯ã次åŒ
ïŒããã§ïŒ¬ã¯æ°ŽçŽ åååã¯ïŒã18åã®ççŽ ååã
å«æããã¢ã·ã«åºãè¡šããã 11βäœçœ®ã«ããã¯å¡©çŽ ååãè¡šããäžã€ïŒÎ±
äœçœ®ã«ããã¯å¡©çŽ åååã¯èçŽ ååãè¡šãã
ããæã㯠11βäœçœ®ã«ããã¯ãµã€çŽ ååãè¡šããäžã€ïŒ
αäœçœ®ã«ããã¯å¡©çŽ ååãè¡šããïŒ ã®16αâã¡ãã«ãã¬ã°ãã³ç³»ã®æ°èŠãªããã²ã³å
èªå°äœã«ããã ãã¢ã·ã«åºãè¡šãããšãã¯ãããã¯ã奜ãŸã
ãã¯ã飜ååã¯äžé£œåã®èèªé žåã¯ã·ã¯ãèèª
é žãç¹ã«é ¢é žãããããªã³é žãé ªé žãã€ãœé ªé žã
åèé žåã¯ãŠã³ãã·ã«é žã®ãããªã¢ã«ã«ã³é žïŒäŸ
ãã°ã·ã¯ããããã«ãã·ã¯ããã³ãã«åã¯ã·ã¯ã
ããã·ã«ã«ã«ãã³é žãã·ã¯ããããã«ãã·ã¯ãã
ã³ãã«åã¯ã·ã¯ãããã·ã«é ¢é žãã·ã¯ãããã
ã«ãã·ã¯ããã³ãã«åã¯ã·ã¯ãããã·ã«ããããª
ã³é žã®ãããªã·ã¯ãã¢ã«ãã«ã«ã«ãã³é žåã¯ã·ã¯
ãã¢ã«ãã«ã¢ã«ã«ã³é žïŒãã³ãã³é žåã¯ã€ãœãã³
ãã³é žãåã¯ãé žã®ã¢ã·ã«æ®åºã§ããã ç¹ã«æ¬çºæã¯ããïŒã18åã®ççŽ ååãå«æ
ããã¢ã·ã«åºãè¡šããåŒã®ååç©ãããã«è©³ã
ãã¯ïŒ¬ãã¢ã»ãã«åºãè¡šãããã®ããšïŒžããšã
ã«å¡©çŽ ååãè¡šãããã®ããå¡©çŽ ååãè¡šãã
äžã€ïŒžãèçŽ ååãè¡šãããã®äžŠã³ã«ïŒ¹ããµã€çŽ
ååãè¡šããäžã€ïŒžãå¡©çŽ ååãè¡šãããã®ã«é¢
ããã ãŸããæ¬çºæã®äž»é¡ã¯ããæ°ŽçŽ ååãããã
ãã€ã«åºãã€ãœãã³ããã€ã«åºããã«ãã«åºåã³
ãã³ã¿ãã€ã«åºãããªã矀ããéžã°ããåŒã®å
åç©ãç¹ã«ïŒžåã³ïŒ¹ãå¡©çŽ ååãè¡šããåŒã®å
åç©ã«ããã åŒã®ååç©ã®äžã§ããç¹ã«å®æœäŸã«èšèŒã®ã
ã®ãäžã§ãäŸïŒã®ååç©ããããããšãã§ããã åŒã®ååç©ã¯ãèå³ããè¬çåŠçæ§è³ªã瀺
ãããããã¯ç¹ã«å±æçµè·¯ã«ããé¡èãªæçç掻
æ§ã瀺ããç¹ã«äžè¬ççµè·¯ã«ããæçç掻æ§ããª
ãããã®ãããªå±æçµè·¯ã«ããæçç掻æ§ãšäžè¬
ççµè·¯ã«ãã掻æ§ãšãåé¢ããŠããããšã¯éåžžã«
èå³ãããããªããªãã°ããã®ããšã¯ãã³ã«ããŸ
ã³åã®æšæºçå¯äœçšã®æãã®ãªãè¬çšéã§æ¬çºæ
ã®ååç©ã䜿çšããã®ãå¯èœãªããããããã§ã
ãã ãããã€ãŠããããã®ååç©ã¯ãäŸãã°æ°Žè «ã
ç®èç ãæ»ççãåçš®ã®æ¹¿ç¹åã³æ¥å çŽ æã®ãã
ãªå±éšçççåå¿ãæå¶ããã®ã«çšããããšãã§
ããã ããããŠãåŒã®ååç©ã¯è¬å€ãšããŠçšããã
ãšãã§ããã ãããã®è¬å€ã®äžã§ããç¹ã«å®æœäŸã«èšèŒã®å
åç©ãäžã§ãäŸïŒã®ååç©ããããããšãã§ã
ãã æ¬çºæã¯ã掻æ§æåãšããŠåŒã®ååç©ã®å°ãª
ããšãïŒçš®ãå«æãã補è¬çµæç©ã«åã¶ã ãããã®è£œè¬çµæç©ã¯ãç®èåã³ç²èãžã®å±éš
é©çšã«ããå±ææäžããããšãã§ããã ãããã®è£œè¬çµæç©ã¯ãåºäœåã¯æ¶²äœã§ãã€ãŠ
ããã人ã®å»è¬ã«äžè¬ã«äœ¿çšãããŠãã補è¬åœ¢
æ ãäŸãã°ç²æ«ãè»èãã¯ãªãŒã ãã²ã«åã³ãšãŒ
ããŸã«èª¿åå€ãšããŠæäŸã§ããããããã¯éåžžã®
æ¹æ³ã§è£œé ãããã掻æ§æåã¯ããããã®è£œè¬çµ
æç©ã«äžè¬ã«äœ¿çšãããŠããè£å©å€ãäŸãã°ã¿ã«
ã¯ãã§ãç²ãæ°Žæ§åã¯éæ°Žæ§ããã¯ã«ãåç©åã¯
æ€ç©èµ·æºã®èèªç©è³ªããã©ãã€ã³èªå°äœãã°ãªã³
ãŒã«ãåçš®ã®æ¹¿æœ€ãåæ£åã¯ä¹³åå€åã³ïŒåã¯ïŒ
ä¿åå€äžã«é åããããšãã§ããã æå¹è¬çšéã¯ãç¹ã«ãæ²»çãã¹ã人åã³çç¶ã«
ãã€ãŠå€ãããäŸãã°ãããã¯1.5ïŒ ã®æŽ»æ§æå
ãå«æããè»èã«ã€ããŠïŒæ¥åœãïŒãïŒåã®é©çš
ã§ãã€ãŠããã ãŸããæ¬çºæã®äž»é¡ã¯ãåŒã®ååç©ã®è£œé æ³
ã§ãã€ãŠãæ¬¡åŒ ïŒããã§ïŒ¬ã¯åèšã®æå³ãæããïŒ ã®ååç©ã«ãïŒÎ±äœçœ®ã«ããã²ã³åååã³11β
äœçœ®ã«å¥ã®ããã²ã³ååïŒïŒžåã³ïŒ¹ã¯åèšã®æ
å³ãæããïŒãå°å ¥ã§ããããã²ã³åå€ãäœçšã
ããŠå¯Ÿå¿ããåŒã®ååç©ãåŸãããšãç¹åŸŽãšã
ãæ¹æ³ã«ããã ç¹ã«ãæ¬çºæã®äž»é¡ã¯ãããã²ã³åå€ãâ
ã¹ã¯ã·ã³ã€ããåã¯ïŒ®âã¢ã»ãã¢ãããšããã²
ã³åç©ã€ãªã³Y-ãäžããè©Šå€ãšã®æ··åç©ïŒïŒžå
ã³ïŒ¹ã¯åèšãšåãæå³ãæããïŒãããªãããšã
ç¹åŸŽãšããæ¹æ³ã«ããã ããã²ã³åå€ãç¹ã«ããã²ã³åç©ã€ãªã³ãäžã
ãè©Šå€ãšããŠã¯ããããã²ã³ååãè¡šããé ž
HYãçšããããšãã§ããããŸãããã²ã³åãªã
ãŠã YLiãé žåªè³ªäžã§çšããããšãã§ããã æ¬çºæã®æ¹æ³ãå®æœãã奜ãŸããæ¹æ³ã«ãããŠ
ã¯ãããã²ã³åãªããŠã ã¯é ¢é žåªè³ªäžã§çšããã
ãã ãŸããæ¬çºæã®äž»é¡ã¯ãåŒã®ååç©ã補é ã
ãæ¹æ³ã®å¥æ³ã«ããããã®å¥æ³ã¯ãŸãåèšã®è£œé
æ³ã«åŸã€ãŠåŒã®ååç©ã補é ãããããŠïŒ¬ãïŒ
ã18åã®ççŽ ååãå«æããã¢ã·ã«åºãè¡šããåŒ
ã®ååç©ã«ããåå€ãäœçšãããŠããæ°ŽçŽ å
åãè¡šããåŒã®å¯Ÿå¿ååç©ãåŸãææãªãã°ã
ã®ååç©ã«ãšã¹ãã«åå€ãäœçšãããæãã¯ïŒ¬ã
æ°ŽçŽ ååãè¡šããåŒã®ååç©ã«ãšã¹ãã«åå€ã
äœçšãããããšãç¹åŸŽãšãããã®ã§ããã ãã®æ¬çºæã®å¥æ³ãå®æœãã奜ãŸããæ¹æ³ã«ã
ããŠãçšããããããåå€ã¯å¥œãŸããã¯æ°Žé žåã
ããªãŠã åã¯æ°Žé žåã«ãªãŠã ããããªãŠã ã¢ã
ããã«ãªãŠã ïœâããã©ãŒãã®ãããªã¢ã«ã«ãªæ§
å¡©åºã§ãããããååå¿ã¯å¥œãŸããã¯ã¡ã¿ããŒã«
åã¯ãšã¿ããŒã«ã®ãããªã¢ã«ã³ãŒã«äžã§è¡ãªãã
ãã çšãããããšã¹ãã«åå€ã¯å¥œãŸããã¯é žåã¯é ž
ç¡æ°Žç©è¥ããã¯é žããã²ã³åç©ãäŸãã°å¡©åç©è¥
ããã¯èåç©ã®ãããªé žå®èœæ§èªå°äœã§ããã ãšã¹ãã«ååå¿ã¯ã奜ãŸããã¯ãäŸãã°ããªãž
ã³è¥ããã¯ã³ãªãžã³ã®ãããªå¡©åºæ§è©Šå€ã®ååšäž
ã«ãåã¯ãžã¡ãã«ãã«ã ã¢ãããžããªãã³ãã«ã¢
ã»ã¿ãŒã«ã®ãããªçž®åå€ã®ååšäžã«è¡ãªãããã åºçºç©è³ªãšããŠçšããããåŒã®ååç©ã¯äžè¬
ã«ç¥ãããŠããããããã¯ãäŸãã°ãã©ã³ã¹ç¹èš±
第1296544å·åã³1461655å·ã«èšèŒã®æ¹æ³ã«ãã€ãŠ
補é ããããšãã§ããã ããã§æ¬çºæã®å®æœäŸã瀺ãã äŸ ïŒ ïŒÎ±ã»11βâãžã¯ãã«â16αâã¡ãã«â21âã¢
ã»ããã·ãã¬ã°ãâïŒã»ïŒâãžãšã³âïŒã»20â
ãžãªã³ 200c.c.ã®é ¢é žã«ïŒïœã®16αâã¡ãã«â21âã¢ã»
ããã·ãã¬ã°ãâïŒã»ïŒã»ïŒ(11)âããªãšã³âïŒã»
20âãžãªã³ãš20ïœã®ç¡æ°Žå¡©åãªããŠã ãçªçŽ æ°æµ
äžã«ãããŸããªããå°å ¥ãããåå¿æ··åç©ãïŒâ
ã«å·åŽãã1.9ïœã®ïŒ®âã¯ãã«ã¹ã¯ã·ã³ã€ããã
å ãã次ãã§520mgã®å¡©é žã¬ã¹ãïŒc.c.ã®ããã©ã
ãããã©ã³ã«æº¶è§£ãã溶液ãå ããããã®åå¿æ··
åç©ã20âã§ïŒæéãããŸãç¶ãã次ãã§ã¢ã€ã¹
ããã¯ã¹ã«äžå€å ¥ãããåå¿æ··åç©ãæ°Žãšæ°·ãšã®
æ··åç©ã«æ³šããåŸãããæ²æ®¿ãç空éããæ°Žæ°Ž
æŽãã也ç¥ããã5.7ïœã®çæç©ãåŸããããã€
ãœãããã«ãšãŒãã«âã¡ã¿ããŒã«âå¡©åã¡ãã¬ã³
æ··åç©ããåçµæ¶ããããšã«ãã粟補ããŠã214
âã§è解ãã2.4ïœã®ïŒÎ±ã»11βâãžã¯ãã«â16
αâã¡ãã«â21âã¢ã»ããã·ãã¬ã°ãâïŒã»ïŒâ
ãžãšã³âïŒã»20âãžãªã³ãåŸãã äŸ ïŒ ïŒÎ±âããã â11βâã¯ãã«â16αâã¡ãã«â
21âã¢ã»ããã·ãã¬ã°ãâïŒã»ïŒâãžãšã³â
ïŒã»20âãžãªã³ 120c.c.ã®é ¢é žã«ïŒïœã®16αâã¡ãã«â21âã¢ã»
ããã·ãã¬ã°ãâïŒã»ïŒã»ïŒ(11)âããªãšã³ãå°å ¥
ããããã®ããã«ããŠåŸããã溶液ã«12ïœã®å¡©å
ãªããŠã ãå ãããå®å šã«æº¶è§£ãããŸã§ãããŸã
ããïŒãïŒïŒâãšãªãã1.32ïœã®ïŒ®âããã ã¢ã»
ãã¢ãããå ããã次ãã§ç¡æ°Žå¡©é žãããã©ãã
ããã©ã³ã«æº¶è§£ãã溶液ïŒããã©ããããã©ã³ïŒ
c.c.åœã140mgã®å¡©é žã¬ã¹ãå«æïŒïŒc.c.ãå ããã
åšå²æž©åºŠã§ïŒæé45åãããŸãããæ°Žã«æ³šå ¥ãã
åŸãããæ²æ®¿ãéããæ°ŽæŽããæžå§äžã«ä¹Ÿç¥ã
ããããããŠã190âã§è解ãã3.76ïœã®ïŒÎ±â
ããã â11βâã¯ãã«â16αâã¡ãã«â21âã¢ã»
ããã·ãã¬ã°ãâïŒã»ïŒâãžãšã³âïŒã»20âãžãª
ã³ãåŸãã äŸ ïŒ ïŒÎ±âã¯ãã«â11βâãã«ãªã«â16αâã¡ãã«
â21âã¢ã»ããã·ãã¬ã°ãâïŒã»ïŒâãžãšã³â
ïŒã»20âãžãªã³ 23.7ïœã®ç¡æ°Žãµã€åæ°ŽçŽ é žã50c.c.ã®ããã©ãã
ããã©ã³äžã«å«ã溶液ã«ïŒïœã®16αâã¡ãã«â21
âã¢ã»ããã·ãã¬ã°ãâïŒã»ïŒã»ïŒ(11)âããªãšã³
âïŒã»20âãžãªã³ãš1.2ïœã®ïŒ®âã¯ãã«ã¹ã¯ã·ã³
ã€ããããããŸããªããå°å ¥ããããã®åå¿æ··å
ç©ã20âã§ïŒæéãããŸãç¶ããåã³0.2ïœã®ïŒ®
âã¯ãã«ã¹ã¯ã·ã³ã€ãããå ããã30åãããŸã
ç¶ãããå·åŽãã也ç¥éçé žãããªãŠã ãå ãã
éçé žãããªãŠã 氎溶液ã«æ³šãããšãŒãã«ã§æœåº
ããããã®çæç©ïŒïŒïŒãã³ãŒã³âé ¢é žãšãã«æ··
åç©ãçšããŠã·ãªã«ã§ïŒåã¯ãããã°ã©ãã€ãŒãš
ãããã€ãœãããã«ãšãŒãã«ããåçµæ¶ããåŸã
180âã§è解ãã1.167ïœã®ïŒÎ±âã¯ãã«â11βâ
ãã«ãªã«â16αâã¡ãã«â21âã¢ã»ããã·ãã¬ã°
ãâïŒã»ïŒâãžãšã³âïŒã»20âãžãªã³ãåŸãã äŸ ïŒ ïŒÎ±ã»11βâãžã¯ãã«â16αâã¡ãã«â21âã
ãããã·ãã¬ã°ãâïŒã»ïŒâãžãšã³âïŒã»20â
ãžãªã³ 156c.c.ã®ã¡ã¿ããŒã«ã«19.45ïœã®ïŒÎ±ã»11βâãž
ã¯ãã«â16αâã¡ãã«â21âã¢ã»ããã·ãã¬ã°ã
âïŒã»ïŒâãžãšã³âïŒã»20âãžãªã³ïŒäŸïŒã«èš
èŒïŒãå°å ¥ãããåŸããã溶液ã«2.5ïŒ ã®æ°Žé žå
ã«ãªãŠã ãå«æããã¡ã¿ããŒã«æº¶æ¶²78c.c.ãå ã
ããïŒæéãã®ãŸãŸæŸçœ®ããåå¿æ··åç©ãæ°·æ°Žã«
泚ããé ¢é žã§äžåãããåŸãããæ²æ®¿ãéãã
æ°ŽæŽãã也ç¥ãããããããŠã215âã§è解ãã
17.25ïœã®ååç©ãåŸãã äŸ ïŒ ïŒÎ±ã»11βâãžã¯ãã«â16αâã¡ãã«â21âã
ãããã€ã«ãªãã·ãã¬ã°ãâïŒã»ïŒâãžãšã³â
ïŒã»20âãžãªã³ 20c.c.ã®ããªãžã³ã«2.5ïœã®äŸïŒã®ååç©ã溶解
ããïŒc.c.ã®ç¡æ°Žããããªã³é žãå ããïŒæéãã®
ãŸãŸã«ããæ°·æ°Žã«æ³šãã15åéæŸçœ®ããç空é
ããæ°ŽæŽãã也ç¥ãã2.9ïœã®ç²çæç©ãåŸãã
ãã15ïŒïŒã¡ã¿ããŒã«âã¯ãããã«ã æ··åç©ã§æº¶
解ããã æ¿çž®ããå·åŽããç空éãã也ç¥ãã2.6ïœ
ã®çæç©ãåŸããããé ¢é žãšãã«ããåçµæ¶ã
ãã200âã§è解ãã2.4ïœã®ææååç©ãåŸãã äŸ ïŒ ïŒÎ±ã»11βâãžã¯ãã«â16αâã¡ãã«â21âã€
ãœãã³ããã€ã«ãªãã·ãã¬ã°ãâïŒã»ïŒâãžãš
ã³âïŒã»20âãžãªã³ ïŒïœã®äŸïŒã®ååç©ã50c.c.ã®ããã©ããããã©
ã³ã1.6ïœã®ã€ãœãã³ãã³é žåã³2.8c.c.ã®ãžã¡ãã«
ãã«ã ã¢ãããžããªãã³ãã«ã¢ã»ã¿ãŒã«ãæ··å
ããéæµãããïŒæé15åä¿ã¡ã次ãã§ä¹Ÿåºã
ããã·ãªã«ã®ã«ã©ã ã«éããïŒïŒïŒãã³ãŒã³âé ¢
é žãšãã«æ··åç©ã§æº¶é¢ããŠç²Ÿè£œããïŒïœã®ç²çæ
ç©ãåŸããããïŒïŒïŒé ¢é žãšãã«ãã¡ã¿ããŒã«æ··
åç©ããåçµæ¶ãã160âã§è解ãã1.5ïœã®ææ
ååç©ãåŸãã äŸ ïŒ ïŒÎ±ã»11βâãžã¯ãã«â16αâã¡ãã«â21âã
ã«ãã«ãªãã·ãã¬ã°ãâïŒã»ïŒâãžãšã³âïŒã»
20âãžãªã³ 氷济äžã§6.25c.c.ã®98ïŒ ãé žæº¶æ¶²ã«12.5c.c.ã®çŽç¡
æ°Žé ¢é žã滎äžããçªçŽ é°å²æ°äžã«50âã§15åãã
ãŸããïŒâã«å·åŽãã次ãã§1875c.c.ã®ããªãžã³ã
å ããïŒâã§ïŒåéæŸçœ®ããã次ãã§2.5ïœã®äŸ
ïŒã®ååç©ãå ããïŒâã§ïŒæéæŸçœ®ããã500
c.c.ã®æ°·æ°Žã«æ³šãã15åæŸçœ®ããç空éãã也ç¥
ãã2.6ïœã®ç²çæç©ãåŸãããã26c.c.ã®ã€ãœã
ããã«ãšãŒãã«ãš20.8c.c.ã®ã¡ã¿ããŒã«ãšã®æ··åç©
ã«æº¶è§£ãããæ¿çž®ããå·åŽããç空éãã也ç¥
ãã2.3ïœã®çæç©ãåŸããããé ¢é žãšãã«ãã
åçµæ¶ãã170âã§è解ãã2.1ïœã®ææååç©ã
åŸãã äŸ ïŒ ïŒÎ±ã»11βâãžã¯ãã«â16αâã¡ãã«â21âã
ã³ã¿ãã€ã«ãªãã·ãã¬ã°ãâïŒã»ïŒâãžãšã³â
ïŒã»20âãžãªã³ 2.5ïœã®äŸïŒã®ååç©ã7.5c.c.ã®ããªãžã³2.5c.c.ã®
ç¡æ°Žãã³ã¿ã³é žãæ··åããïŒæéåŸã«200mlã®æ°·
æ°Žã«æ³šãã次ãã§ã¯ãããã«ã ã§æœåºããææ©çž
ãé 次ã«1Nå¡©é žæ°Žæº¶æ¶²ãéçé žãããªãŠã 飜å
溶液ã次ãã§æ°Žã§ïŒåæŽæµããã è±æ°Žãã也åºããã3.9ïœã®ç²çæç©ãåŸãã
ããã·ãªã«ã«ã©ã ã«éããïŒïŒïŒãšãã«ãšãŒãã«
âç³æ²¹ãšãŒãã«ïŒBPïŒ60ã80âïŒæ··åç©ã§æº¶é¢
ããŠç²Ÿè£œããã3.3ïœã®çæç©ãåŸããããïŒc.c.
ã®ãšãã«ãšãŒãã«ãš11.6c.c.ã®ã€ãœãããã«ãšãŒã
ã«ãšã®æ··åç©ã«æº¶è§£ããã å·åŽããç空éããè±æ°Žãã2.6ïœã®ææå
åç©ãåŸãããã3.9c.c.ã®ãšãã«ãšãŒãã«ãšïŒc.c.
ã®ã€ãœãããã«ãšãŒãã«ãšã®æ··åç©ããåçµæ¶ã
ããããããŠ76âã§è解ãã2.1ïœã®ææååç©
ãåŸãã äŸ ïŒ äžèšã®åŠæ¹ã«çžåœããå±éšé©çšã®ããã®è»èã
äœã€ãã äŸïŒã®ååç© 1.5ïœ è£å©å€ 100ïœãšããã«å åãªé ïŒè£å©å€ã®è©³çŽ°ïŒã©ããªã³åã³ã¯ã»ãªã³ïŒ äŸ 10 äžèšã®åŠæ¹ã«çžåœããå±éšé©çšã®ããã®è»èã
äœã€ãã äŸïŒã®ååç© 1.5ïœ è£å©å€ 100ïœãšããã«å åãªé ïŒè£å©å€ã®è©³çŽ°ïŒã©ããªã³åã³ã¯ã»ãªã³ïŒ è¬çåŠçç 究 ïŒÎ±ã»11βâãžã¯ãã«â16αâã¡ãã«â21âã¢
ã»ããã·ãã¬ã°ãâïŒã»ïŒâãžãšã³âïŒã»20âãž
ãªã³ïŒååç©ïŒ¡ïŒãïŒÎ±âããã â11βâã¯ãã«
â16αâã¡ãã«â21âã¢ã»ããã·ãã¬ã°ãâïŒã»
ïŒâãžãšã³âïŒã»20âãžãªã³ïŒååç©ïŒ¢ïŒãïŒÎ±
âã¯ãã«â11βâãã«ãªã«â16αâã¡ãã«â21â
ã¢ã»ããã·ãã¬ã°ãâïŒã»ïŒâãžãšã³âïŒã»20â
ãžãªã³ïŒååç©ïŒ£ïŒãïŒÎ±ã»11βâãžã¯ãã«â16
αâã¡ãã«â21âããããã·ãã¬ã°ãâïŒã»ïŒâ
ãžãšã³âïŒã»20âãžãªã³ïŒååç©ïŒ€ïŒãïŒÎ±ã»11
βâãžã¯ãã«â16αâã¡ãã«â21âããããã€ã«
ãªãã·ãã¬ã°ãâïŒã»ïŒâãžãšã³âïŒã»20âãžãª
ã³ïŒååç©ïŒ¥ïŒãïŒÎ±ã»11βâãžã¯ãã«â16αâ
ã¡ãã«â21âãã«ãã«ãªãã·ãã¬ã°ãâïŒã»ïŒâ
ãžãšã³âïŒã»20âãžãªã³ïŒååç©ïŒŠïŒåã³ïŒÎ±ã»
11βâãžã¯ãã«â16αâã¡ãã«â21âãã³ã¿ãã€
ã«ãªãã·ãã¬ã°ãâïŒã»ïŒâãžãšã³âïŒã»20âãž
ãªã³ïŒååç©ïŒ§ïŒããããµã¡ã¿ãŸã³ãšæ¯èŒç 究ã
ãã ååç©ã¯ã0.25ïŒ ã®ã«ã«ããã·ã¡ãã«ã»ã«ããŒ
ã¹ãš0.20ïŒ ã®ããªãœã«ããŒã80ãå«æããæ°Žæ§å
æ£äœãšããŠçšããã (1) çµå£æäžã«ããæçç掻æ§ã®ç 究 æšæºèèœè «è©Šéšã«ããç 究ããã R.Meieræ°ä»ã®æ¹æ³ïŒExperientiaã1950ã
ïŒã469ïŒã®ä¿®æ£æ³ã«ãããäœé100ã110ïœã®
æ®éã®ãŠã€ã¹ã¿ãŒçš®ã®ã©ããã®éã®èžéšã®ç®äž
ã«ããããéãã10mgã®ïŒåã®æšç¶¿çãã¬ãã
ã®ç§»æ€äœã移æ€ãããçµå£æ²»çããã®ç§»æ€çŽåŸ
ã«éå§ããŠïŒæ¥ïŒåã®æäžã®å²åã§ïŒæ¥éç¶ã
ããæåŸã®æåãã16æéåŸãå³ã¡ïŒæ¥ç®ã«å
ç©ã殺ãã çããèèœè «çµç¹ã§åããŸããããã¬ããã
æ°ãããã¡ã«ç§€éãã次ãã§60âã§18æéåŸã«
åã³ç§€éãããèèœè «ã®ééã¯æšç¶¿ã®åæéé
ãå·®ãåŒãããšã«ãã€ãŠåŸãããã ãŸããèèœè «ãšåæã«ååºããèžè ºã®ç§€é
ã¯ãååç©ã®èžè ºçµç¹ç Žå£æŽ»æ§ïŒthymolytic
activityïŒãè©äŸ¡ãããããšã«ãªãã çµæã¯ãAD50ïŒå³ã¡ãèèœè «ã50ïŒ æå¶ã
ããè¬çšéåã³èžè ºã50ïŒ éçž®ãããè¬çšéïŒ
ã§è¡šããããããäžèšã®éãã§ããã
å«æããã¢ã·ã«åºãè¡šããã 11βäœçœ®ã«ããã¯å¡©çŽ ååãè¡šããäžã€ïŒÎ±
äœçœ®ã«ããã¯å¡©çŽ åååã¯èçŽ ååãè¡šãã
ããæã㯠11βäœçœ®ã«ããã¯ãµã€çŽ ååãè¡šããäžã€ïŒ
αäœçœ®ã«ããã¯å¡©çŽ ååãè¡šããïŒ ã®16αâã¡ãã«ãã¬ã°ãã³ç³»ã®æ°èŠãªããã²ã³å
èªå°äœã«ããã ãã¢ã·ã«åºãè¡šãããšãã¯ãããã¯ã奜ãŸã
ãã¯ã飜ååã¯äžé£œåã®èèªé žåã¯ã·ã¯ãèèª
é žãç¹ã«é ¢é žãããããªã³é žãé ªé žãã€ãœé ªé žã
åèé žåã¯ãŠã³ãã·ã«é žã®ãããªã¢ã«ã«ã³é žïŒäŸ
ãã°ã·ã¯ããããã«ãã·ã¯ããã³ãã«åã¯ã·ã¯ã
ããã·ã«ã«ã«ãã³é žãã·ã¯ããããã«ãã·ã¯ãã
ã³ãã«åã¯ã·ã¯ãããã·ã«é ¢é žãã·ã¯ãããã
ã«ãã·ã¯ããã³ãã«åã¯ã·ã¯ãããã·ã«ããããª
ã³é žã®ãããªã·ã¯ãã¢ã«ãã«ã«ã«ãã³é žåã¯ã·ã¯
ãã¢ã«ãã«ã¢ã«ã«ã³é žïŒãã³ãã³é žåã¯ã€ãœãã³
ãã³é žãåã¯ãé žã®ã¢ã·ã«æ®åºã§ããã ç¹ã«æ¬çºæã¯ããïŒã18åã®ççŽ ååãå«æ
ããã¢ã·ã«åºãè¡šããåŒã®ååç©ãããã«è©³ã
ãã¯ïŒ¬ãã¢ã»ãã«åºãè¡šãããã®ããšïŒžããšã
ã«å¡©çŽ ååãè¡šãããã®ããå¡©çŽ ååãè¡šãã
äžã€ïŒžãèçŽ ååãè¡šãããã®äžŠã³ã«ïŒ¹ããµã€çŽ
ååãè¡šããäžã€ïŒžãå¡©çŽ ååãè¡šãããã®ã«é¢
ããã ãŸããæ¬çºæã®äž»é¡ã¯ããæ°ŽçŽ ååãããã
ãã€ã«åºãã€ãœãã³ããã€ã«åºããã«ãã«åºåã³
ãã³ã¿ãã€ã«åºãããªã矀ããéžã°ããåŒã®å
åç©ãç¹ã«ïŒžåã³ïŒ¹ãå¡©çŽ ååãè¡šããåŒã®å
åç©ã«ããã åŒã®ååç©ã®äžã§ããç¹ã«å®æœäŸã«èšèŒã®ã
ã®ãäžã§ãäŸïŒã®ååç©ããããããšãã§ããã åŒã®ååç©ã¯ãèå³ããè¬çåŠçæ§è³ªã瀺
ãããããã¯ç¹ã«å±æçµè·¯ã«ããé¡èãªæçç掻
æ§ã瀺ããç¹ã«äžè¬ççµè·¯ã«ããæçç掻æ§ããª
ãããã®ãããªå±æçµè·¯ã«ããæçç掻æ§ãšäžè¬
ççµè·¯ã«ãã掻æ§ãšãåé¢ããŠããããšã¯éåžžã«
èå³ãããããªããªãã°ããã®ããšã¯ãã³ã«ããŸ
ã³åã®æšæºçå¯äœçšã®æãã®ãªãè¬çšéã§æ¬çºæ
ã®ååç©ã䜿çšããã®ãå¯èœãªããããããã§ã
ãã ãããã€ãŠããããã®ååç©ã¯ãäŸãã°æ°Žè «ã
ç®èç ãæ»ççãåçš®ã®æ¹¿ç¹åã³æ¥å çŽ æã®ãã
ãªå±éšçççåå¿ãæå¶ããã®ã«çšããããšãã§
ããã ããããŠãåŒã®ååç©ã¯è¬å€ãšããŠçšããã
ãšãã§ããã ãããã®è¬å€ã®äžã§ããç¹ã«å®æœäŸã«èšèŒã®å
åç©ãäžã§ãäŸïŒã®ååç©ããããããšãã§ã
ãã æ¬çºæã¯ã掻æ§æåãšããŠåŒã®ååç©ã®å°ãª
ããšãïŒçš®ãå«æãã補è¬çµæç©ã«åã¶ã ãããã®è£œè¬çµæç©ã¯ãç®èåã³ç²èãžã®å±éš
é©çšã«ããå±ææäžããããšãã§ããã ãããã®è£œè¬çµæç©ã¯ãåºäœåã¯æ¶²äœã§ãã€ãŠ
ããã人ã®å»è¬ã«äžè¬ã«äœ¿çšãããŠãã補è¬åœ¢
æ ãäŸãã°ç²æ«ãè»èãã¯ãªãŒã ãã²ã«åã³ãšãŒ
ããŸã«èª¿åå€ãšããŠæäŸã§ããããããã¯éåžžã®
æ¹æ³ã§è£œé ãããã掻æ§æåã¯ããããã®è£œè¬çµ
æç©ã«äžè¬ã«äœ¿çšãããŠããè£å©å€ãäŸãã°ã¿ã«
ã¯ãã§ãç²ãæ°Žæ§åã¯éæ°Žæ§ããã¯ã«ãåç©åã¯
æ€ç©èµ·æºã®èèªç©è³ªããã©ãã€ã³èªå°äœãã°ãªã³
ãŒã«ãåçš®ã®æ¹¿æœ€ãåæ£åã¯ä¹³åå€åã³ïŒåã¯ïŒ
ä¿åå€äžã«é åããããšãã§ããã æå¹è¬çšéã¯ãç¹ã«ãæ²»çãã¹ã人åã³çç¶ã«
ãã€ãŠå€ãããäŸãã°ãããã¯1.5ïŒ ã®æŽ»æ§æå
ãå«æããè»èã«ã€ããŠïŒæ¥åœãïŒãïŒåã®é©çš
ã§ãã€ãŠããã ãŸããæ¬çºæã®äž»é¡ã¯ãåŒã®ååç©ã®è£œé æ³
ã§ãã€ãŠãæ¬¡åŒ ïŒããã§ïŒ¬ã¯åèšã®æå³ãæããïŒ ã®ååç©ã«ãïŒÎ±äœçœ®ã«ããã²ã³åååã³11β
äœçœ®ã«å¥ã®ããã²ã³ååïŒïŒžåã³ïŒ¹ã¯åèšã®æ
å³ãæããïŒãå°å ¥ã§ããããã²ã³åå€ãäœçšã
ããŠå¯Ÿå¿ããåŒã®ååç©ãåŸãããšãç¹åŸŽãšã
ãæ¹æ³ã«ããã ç¹ã«ãæ¬çºæã®äž»é¡ã¯ãããã²ã³åå€ãâ
ã¹ã¯ã·ã³ã€ããåã¯ïŒ®âã¢ã»ãã¢ãããšããã²
ã³åç©ã€ãªã³Y-ãäžããè©Šå€ãšã®æ··åç©ïŒïŒžå
ã³ïŒ¹ã¯åèšãšåãæå³ãæããïŒãããªãããšã
ç¹åŸŽãšããæ¹æ³ã«ããã ããã²ã³åå€ãç¹ã«ããã²ã³åç©ã€ãªã³ãäžã
ãè©Šå€ãšããŠã¯ããããã²ã³ååãè¡šããé ž
HYãçšããããšãã§ããããŸãããã²ã³åãªã
ãŠã YLiãé žåªè³ªäžã§çšããããšãã§ããã æ¬çºæã®æ¹æ³ãå®æœãã奜ãŸããæ¹æ³ã«ãããŠ
ã¯ãããã²ã³åãªããŠã ã¯é ¢é žåªè³ªäžã§çšããã
ãã ãŸããæ¬çºæã®äž»é¡ã¯ãåŒã®ååç©ã補é ã
ãæ¹æ³ã®å¥æ³ã«ããããã®å¥æ³ã¯ãŸãåèšã®è£œé
æ³ã«åŸã€ãŠåŒã®ååç©ã補é ãããããŠïŒ¬ãïŒ
ã18åã®ççŽ ååãå«æããã¢ã·ã«åºãè¡šããåŒ
ã®ååç©ã«ããåå€ãäœçšãããŠããæ°ŽçŽ å
åãè¡šããåŒã®å¯Ÿå¿ååç©ãåŸãææãªãã°ã
ã®ååç©ã«ãšã¹ãã«åå€ãäœçšãããæãã¯ïŒ¬ã
æ°ŽçŽ ååãè¡šããåŒã®ååç©ã«ãšã¹ãã«åå€ã
äœçšãããããšãç¹åŸŽãšãããã®ã§ããã ãã®æ¬çºæã®å¥æ³ãå®æœãã奜ãŸããæ¹æ³ã«ã
ããŠãçšããããããåå€ã¯å¥œãŸããã¯æ°Žé žåã
ããªãŠã åã¯æ°Žé žåã«ãªãŠã ããããªãŠã ã¢ã
ããã«ãªãŠã ïœâããã©ãŒãã®ãããªã¢ã«ã«ãªæ§
å¡©åºã§ãããããååå¿ã¯å¥œãŸããã¯ã¡ã¿ããŒã«
åã¯ãšã¿ããŒã«ã®ãããªã¢ã«ã³ãŒã«äžã§è¡ãªãã
ãã çšãããããšã¹ãã«åå€ã¯å¥œãŸããã¯é žåã¯é ž
ç¡æ°Žç©è¥ããã¯é žããã²ã³åç©ãäŸãã°å¡©åç©è¥
ããã¯èåç©ã®ãããªé žå®èœæ§èªå°äœã§ããã ãšã¹ãã«ååå¿ã¯ã奜ãŸããã¯ãäŸãã°ããªãž
ã³è¥ããã¯ã³ãªãžã³ã®ãããªå¡©åºæ§è©Šå€ã®ååšäž
ã«ãåã¯ãžã¡ãã«ãã«ã ã¢ãããžããªãã³ãã«ã¢
ã»ã¿ãŒã«ã®ãããªçž®åå€ã®ååšäžã«è¡ãªãããã åºçºç©è³ªãšããŠçšããããåŒã®ååç©ã¯äžè¬
ã«ç¥ãããŠããããããã¯ãäŸãã°ãã©ã³ã¹ç¹èš±
第1296544å·åã³1461655å·ã«èšèŒã®æ¹æ³ã«ãã€ãŠ
補é ããããšãã§ããã ããã§æ¬çºæã®å®æœäŸã瀺ãã äŸ ïŒ ïŒÎ±ã»11βâãžã¯ãã«â16αâã¡ãã«â21âã¢
ã»ããã·ãã¬ã°ãâïŒã»ïŒâãžãšã³âïŒã»20â
ãžãªã³ 200c.c.ã®é ¢é žã«ïŒïœã®16αâã¡ãã«â21âã¢ã»
ããã·ãã¬ã°ãâïŒã»ïŒã»ïŒ(11)âããªãšã³âïŒã»
20âãžãªã³ãš20ïœã®ç¡æ°Žå¡©åãªããŠã ãçªçŽ æ°æµ
äžã«ãããŸããªããå°å ¥ãããåå¿æ··åç©ãïŒâ
ã«å·åŽãã1.9ïœã®ïŒ®âã¯ãã«ã¹ã¯ã·ã³ã€ããã
å ãã次ãã§520mgã®å¡©é žã¬ã¹ãïŒc.c.ã®ããã©ã
ãããã©ã³ã«æº¶è§£ãã溶液ãå ããããã®åå¿æ··
åç©ã20âã§ïŒæéãããŸãç¶ãã次ãã§ã¢ã€ã¹
ããã¯ã¹ã«äžå€å ¥ãããåå¿æ··åç©ãæ°Žãšæ°·ãšã®
æ··åç©ã«æ³šããåŸãããæ²æ®¿ãç空éããæ°Žæ°Ž
æŽãã也ç¥ããã5.7ïœã®çæç©ãåŸããããã€
ãœãããã«ãšãŒãã«âã¡ã¿ããŒã«âå¡©åã¡ãã¬ã³
æ··åç©ããåçµæ¶ããããšã«ãã粟補ããŠã214
âã§è解ãã2.4ïœã®ïŒÎ±ã»11βâãžã¯ãã«â16
αâã¡ãã«â21âã¢ã»ããã·ãã¬ã°ãâïŒã»ïŒâ
ãžãšã³âïŒã»20âãžãªã³ãåŸãã äŸ ïŒ ïŒÎ±âããã â11βâã¯ãã«â16αâã¡ãã«â
21âã¢ã»ããã·ãã¬ã°ãâïŒã»ïŒâãžãšã³â
ïŒã»20âãžãªã³ 120c.c.ã®é ¢é žã«ïŒïœã®16αâã¡ãã«â21âã¢ã»
ããã·ãã¬ã°ãâïŒã»ïŒã»ïŒ(11)âããªãšã³ãå°å ¥
ããããã®ããã«ããŠåŸããã溶液ã«12ïœã®å¡©å
ãªããŠã ãå ãããå®å šã«æº¶è§£ãããŸã§ãããŸã
ããïŒãïŒïŒâãšãªãã1.32ïœã®ïŒ®âããã ã¢ã»
ãã¢ãããå ããã次ãã§ç¡æ°Žå¡©é žãããã©ãã
ããã©ã³ã«æº¶è§£ãã溶液ïŒããã©ããããã©ã³ïŒ
c.c.åœã140mgã®å¡©é žã¬ã¹ãå«æïŒïŒc.c.ãå ããã
åšå²æž©åºŠã§ïŒæé45åãããŸãããæ°Žã«æ³šå ¥ãã
åŸãããæ²æ®¿ãéããæ°ŽæŽããæžå§äžã«ä¹Ÿç¥ã
ããããããŠã190âã§è解ãã3.76ïœã®ïŒÎ±â
ããã â11βâã¯ãã«â16αâã¡ãã«â21âã¢ã»
ããã·ãã¬ã°ãâïŒã»ïŒâãžãšã³âïŒã»20âãžãª
ã³ãåŸãã äŸ ïŒ ïŒÎ±âã¯ãã«â11βâãã«ãªã«â16αâã¡ãã«
â21âã¢ã»ããã·ãã¬ã°ãâïŒã»ïŒâãžãšã³â
ïŒã»20âãžãªã³ 23.7ïœã®ç¡æ°Žãµã€åæ°ŽçŽ é žã50c.c.ã®ããã©ãã
ããã©ã³äžã«å«ã溶液ã«ïŒïœã®16αâã¡ãã«â21
âã¢ã»ããã·ãã¬ã°ãâïŒã»ïŒã»ïŒ(11)âããªãšã³
âïŒã»20âãžãªã³ãš1.2ïœã®ïŒ®âã¯ãã«ã¹ã¯ã·ã³
ã€ããããããŸããªããå°å ¥ããããã®åå¿æ··å
ç©ã20âã§ïŒæéãããŸãç¶ããåã³0.2ïœã®ïŒ®
âã¯ãã«ã¹ã¯ã·ã³ã€ãããå ããã30åãããŸã
ç¶ãããå·åŽãã也ç¥éçé žãããªãŠã ãå ãã
éçé žãããªãŠã 氎溶液ã«æ³šãããšãŒãã«ã§æœåº
ããããã®çæç©ïŒïŒïŒãã³ãŒã³âé ¢é žãšãã«æ··
åç©ãçšããŠã·ãªã«ã§ïŒåã¯ãããã°ã©ãã€ãŒãš
ãããã€ãœãããã«ãšãŒãã«ããåçµæ¶ããåŸã
180âã§è解ãã1.167ïœã®ïŒÎ±âã¯ãã«â11βâ
ãã«ãªã«â16αâã¡ãã«â21âã¢ã»ããã·ãã¬ã°
ãâïŒã»ïŒâãžãšã³âïŒã»20âãžãªã³ãåŸãã äŸ ïŒ ïŒÎ±ã»11βâãžã¯ãã«â16αâã¡ãã«â21âã
ãããã·ãã¬ã°ãâïŒã»ïŒâãžãšã³âïŒã»20â
ãžãªã³ 156c.c.ã®ã¡ã¿ããŒã«ã«19.45ïœã®ïŒÎ±ã»11βâãž
ã¯ãã«â16αâã¡ãã«â21âã¢ã»ããã·ãã¬ã°ã
âïŒã»ïŒâãžãšã³âïŒã»20âãžãªã³ïŒäŸïŒã«èš
èŒïŒãå°å ¥ãããåŸããã溶液ã«2.5ïŒ ã®æ°Žé žå
ã«ãªãŠã ãå«æããã¡ã¿ããŒã«æº¶æ¶²78c.c.ãå ã
ããïŒæéãã®ãŸãŸæŸçœ®ããåå¿æ··åç©ãæ°·æ°Žã«
泚ããé ¢é žã§äžåãããåŸãããæ²æ®¿ãéãã
æ°ŽæŽãã也ç¥ãããããããŠã215âã§è解ãã
17.25ïœã®ååç©ãåŸãã äŸ ïŒ ïŒÎ±ã»11βâãžã¯ãã«â16αâã¡ãã«â21âã
ãããã€ã«ãªãã·ãã¬ã°ãâïŒã»ïŒâãžãšã³â
ïŒã»20âãžãªã³ 20c.c.ã®ããªãžã³ã«2.5ïœã®äŸïŒã®ååç©ã溶解
ããïŒc.c.ã®ç¡æ°Žããããªã³é žãå ããïŒæéãã®
ãŸãŸã«ããæ°·æ°Žã«æ³šãã15åéæŸçœ®ããç空é
ããæ°ŽæŽãã也ç¥ãã2.9ïœã®ç²çæç©ãåŸãã
ãã15ïŒïŒã¡ã¿ããŒã«âã¯ãããã«ã æ··åç©ã§æº¶
解ããã æ¿çž®ããå·åŽããç空éãã也ç¥ãã2.6ïœ
ã®çæç©ãåŸããããé ¢é žãšãã«ããåçµæ¶ã
ãã200âã§è解ãã2.4ïœã®ææååç©ãåŸãã äŸ ïŒ ïŒÎ±ã»11βâãžã¯ãã«â16αâã¡ãã«â21âã€
ãœãã³ããã€ã«ãªãã·ãã¬ã°ãâïŒã»ïŒâãžãš
ã³âïŒã»20âãžãªã³ ïŒïœã®äŸïŒã®ååç©ã50c.c.ã®ããã©ããããã©
ã³ã1.6ïœã®ã€ãœãã³ãã³é žåã³2.8c.c.ã®ãžã¡ãã«
ãã«ã ã¢ãããžããªãã³ãã«ã¢ã»ã¿ãŒã«ãæ··å
ããéæµãããïŒæé15åä¿ã¡ã次ãã§ä¹Ÿåºã
ããã·ãªã«ã®ã«ã©ã ã«éããïŒïŒïŒãã³ãŒã³âé ¢
é žãšãã«æ··åç©ã§æº¶é¢ããŠç²Ÿè£œããïŒïœã®ç²çæ
ç©ãåŸããããïŒïŒïŒé ¢é žãšãã«ãã¡ã¿ããŒã«æ··
åç©ããåçµæ¶ãã160âã§è解ãã1.5ïœã®ææ
ååç©ãåŸãã äŸ ïŒ ïŒÎ±ã»11βâãžã¯ãã«â16αâã¡ãã«â21âã
ã«ãã«ãªãã·ãã¬ã°ãâïŒã»ïŒâãžãšã³âïŒã»
20âãžãªã³ 氷济äžã§6.25c.c.ã®98ïŒ ãé žæº¶æ¶²ã«12.5c.c.ã®çŽç¡
æ°Žé ¢é žã滎äžããçªçŽ é°å²æ°äžã«50âã§15åãã
ãŸããïŒâã«å·åŽãã次ãã§1875c.c.ã®ããªãžã³ã
å ããïŒâã§ïŒåéæŸçœ®ããã次ãã§2.5ïœã®äŸ
ïŒã®ååç©ãå ããïŒâã§ïŒæéæŸçœ®ããã500
c.c.ã®æ°·æ°Žã«æ³šãã15åæŸçœ®ããç空éãã也ç¥
ãã2.6ïœã®ç²çæç©ãåŸãããã26c.c.ã®ã€ãœã
ããã«ãšãŒãã«ãš20.8c.c.ã®ã¡ã¿ããŒã«ãšã®æ··åç©
ã«æº¶è§£ãããæ¿çž®ããå·åŽããç空éãã也ç¥
ãã2.3ïœã®çæç©ãåŸããããé ¢é žãšãã«ãã
åçµæ¶ãã170âã§è解ãã2.1ïœã®ææååç©ã
åŸãã äŸ ïŒ ïŒÎ±ã»11βâãžã¯ãã«â16αâã¡ãã«â21âã
ã³ã¿ãã€ã«ãªãã·ãã¬ã°ãâïŒã»ïŒâãžãšã³â
ïŒã»20âãžãªã³ 2.5ïœã®äŸïŒã®ååç©ã7.5c.c.ã®ããªãžã³2.5c.c.ã®
ç¡æ°Žãã³ã¿ã³é žãæ··åããïŒæéåŸã«200mlã®æ°·
æ°Žã«æ³šãã次ãã§ã¯ãããã«ã ã§æœåºããææ©çž
ãé 次ã«1Nå¡©é žæ°Žæº¶æ¶²ãéçé žãããªãŠã 飜å
溶液ã次ãã§æ°Žã§ïŒåæŽæµããã è±æ°Žãã也åºããã3.9ïœã®ç²çæç©ãåŸãã
ããã·ãªã«ã«ã©ã ã«éããïŒïŒïŒãšãã«ãšãŒãã«
âç³æ²¹ãšãŒãã«ïŒBPïŒ60ã80âïŒæ··åç©ã§æº¶é¢
ããŠç²Ÿè£œããã3.3ïœã®çæç©ãåŸããããïŒc.c.
ã®ãšãã«ãšãŒãã«ãš11.6c.c.ã®ã€ãœãããã«ãšãŒã
ã«ãšã®æ··åç©ã«æº¶è§£ããã å·åŽããç空éããè±æ°Žãã2.6ïœã®ææå
åç©ãåŸãããã3.9c.c.ã®ãšãã«ãšãŒãã«ãšïŒc.c.
ã®ã€ãœãããã«ãšãŒãã«ãšã®æ··åç©ããåçµæ¶ã
ããããããŠ76âã§è解ãã2.1ïœã®ææååç©
ãåŸãã äŸ ïŒ äžèšã®åŠæ¹ã«çžåœããå±éšé©çšã®ããã®è»èã
äœã€ãã äŸïŒã®ååç© 1.5ïœ è£å©å€ 100ïœãšããã«å åãªé ïŒè£å©å€ã®è©³çŽ°ïŒã©ããªã³åã³ã¯ã»ãªã³ïŒ äŸ 10 äžèšã®åŠæ¹ã«çžåœããå±éšé©çšã®ããã®è»èã
äœã€ãã äŸïŒã®ååç© 1.5ïœ è£å©å€ 100ïœãšããã«å åãªé ïŒè£å©å€ã®è©³çŽ°ïŒã©ããªã³åã³ã¯ã»ãªã³ïŒ è¬çåŠçç 究 ïŒÎ±ã»11βâãžã¯ãã«â16αâã¡ãã«â21âã¢
ã»ããã·ãã¬ã°ãâïŒã»ïŒâãžãšã³âïŒã»20âãž
ãªã³ïŒååç©ïŒ¡ïŒãïŒÎ±âããã â11βâã¯ãã«
â16αâã¡ãã«â21âã¢ã»ããã·ãã¬ã°ãâïŒã»
ïŒâãžãšã³âïŒã»20âãžãªã³ïŒååç©ïŒ¢ïŒãïŒÎ±
âã¯ãã«â11βâãã«ãªã«â16αâã¡ãã«â21â
ã¢ã»ããã·ãã¬ã°ãâïŒã»ïŒâãžãšã³âïŒã»20â
ãžãªã³ïŒååç©ïŒ£ïŒãïŒÎ±ã»11βâãžã¯ãã«â16
αâã¡ãã«â21âããããã·ãã¬ã°ãâïŒã»ïŒâ
ãžãšã³âïŒã»20âãžãªã³ïŒååç©ïŒ€ïŒãïŒÎ±ã»11
βâãžã¯ãã«â16αâã¡ãã«â21âããããã€ã«
ãªãã·ãã¬ã°ãâïŒã»ïŒâãžãšã³âïŒã»20âãžãª
ã³ïŒååç©ïŒ¥ïŒãïŒÎ±ã»11βâãžã¯ãã«â16αâ
ã¡ãã«â21âãã«ãã«ãªãã·ãã¬ã°ãâïŒã»ïŒâ
ãžãšã³âïŒã»20âãžãªã³ïŒååç©ïŒŠïŒåã³ïŒÎ±ã»
11βâãžã¯ãã«â16αâã¡ãã«â21âãã³ã¿ãã€
ã«ãªãã·ãã¬ã°ãâïŒã»ïŒâãžãšã³âïŒã»20âãž
ãªã³ïŒååç©ïŒ§ïŒããããµã¡ã¿ãŸã³ãšæ¯èŒç 究ã
ãã ååç©ã¯ã0.25ïŒ ã®ã«ã«ããã·ã¡ãã«ã»ã«ããŒ
ã¹ãš0.20ïŒ ã®ããªãœã«ããŒã80ãå«æããæ°Žæ§å
æ£äœãšããŠçšããã (1) çµå£æäžã«ããæçç掻æ§ã®ç 究 æšæºèèœè «è©Šéšã«ããç 究ããã R.Meieræ°ä»ã®æ¹æ³ïŒExperientiaã1950ã
ïŒã469ïŒã®ä¿®æ£æ³ã«ãããäœé100ã110ïœã®
æ®éã®ãŠã€ã¹ã¿ãŒçš®ã®ã©ããã®éã®èžéšã®ç®äž
ã«ããããéãã10mgã®ïŒåã®æšç¶¿çãã¬ãã
ã®ç§»æ€äœã移æ€ãããçµå£æ²»çããã®ç§»æ€çŽåŸ
ã«éå§ããŠïŒæ¥ïŒåã®æäžã®å²åã§ïŒæ¥éç¶ã
ããæåŸã®æåãã16æéåŸãå³ã¡ïŒæ¥ç®ã«å
ç©ã殺ãã çããèèœè «çµç¹ã§åããŸããããã¬ããã
æ°ãããã¡ã«ç§€éãã次ãã§60âã§18æéåŸã«
åã³ç§€éãããèèœè «ã®ééã¯æšç¶¿ã®åæéé
ãå·®ãåŒãããšã«ãã€ãŠåŸãããã ãŸããèèœè «ãšåæã«ååºããèžè ºã®ç§€é
ã¯ãååç©ã®èžè ºçµç¹ç Žå£æŽ»æ§ïŒthymolytic
activityïŒãè©äŸ¡ãããããšã«ãªãã çµæã¯ãAD50ïŒå³ã¡ãèèœè «ã50ïŒ æå¶ã
ããè¬çšéåã³èžè ºã50ïŒ éçž®ãããè¬çšéïŒ
ã§è¡šããããããäžèšã®éãã§ããã
ãè¡šã
ååç©ïŒ¡ãåã³ïŒ£ã¯ãèèœè
«ã®æå¶åã³èž
è ºã®éçž®ã®ç¹ã§ãããµã¡ã¿ãŸã³ãããå°ãªããš
ã1000å掻æ§ãå°ããã ååç©ïŒ€ããåã³ïŒ§ã¯ãèèœè «ã®æå¶ã®
ç¹ã§ãããµã¡ã¿ãŸã³ããã1000å以äžæŽ»æ§ãå°
ããã ååç©ïŒ€ããåã³ïŒ§ã¯ãèžè ºã®éçž®ã®ç¹
ã§çŽ500ã1500å掻æ§ãå°ããã (2) ç®èäžã®æŽ»æ§ã®ç 究 ã¯ãæ²¹ã«ããåŒãèµ·ãããæ°Žè «ã®è©Šéš 䜿çšããæè¡ã¯ãTonelliæ°ä»ã®æè¡
ïŒEncocrinology1965ã77ã625ïŒã«ãã瀺åã
ãããã®ã§ãããæ°Žè «ã¯ããŠã¹ã®äžæ¹ã®è³ã«ã¯
ãæ²¹ãé©çšããããšã«ãã€ãŠåŒãèµ·ãããã (a) å±éšé©çšã«ããæŽ»æ§ ç¬¬äžã®ãããã®ããŠã¹ã«ã¯ãã¯ã油溶液ã
å³è³ã«é©çšããã 第äºã®ãããã®ããŠã¹ã«ã¯ãååç©ïŒ¡ã
ããããåã¯ïŒ§ãåã¯ãããµã¡ã¿
ãŸã³ãå ããã¯ã油溶液ãå³è³ã«é©çšããã ããŠã¹ã®å·Šè³ã«ã¯äœãé©çšããªãã ïŒæéåŸã«è³ãåé€ãã秀éãããå³è³ãš
å·Šè³ãšã®éã®ééå·®ãççã®åºŠåã瀺ãããš
ã«ãªãã çµæã¯ãAC50ãå³ã¡å¯Ÿç §äŸã«ãããŠã¯ã
æ²¹ã«ããåŒãèµ·ãããæ°Žè «ãååãŸã§æžå°ã
ãã掻æ§æ¿åºŠã«ãã€ãŠè¡šããããã
è ºã®éçž®ã®ç¹ã§ãããµã¡ã¿ãŸã³ãããå°ãªããš
ã1000å掻æ§ãå°ããã ååç©ïŒ€ããåã³ïŒ§ã¯ãèèœè «ã®æå¶ã®
ç¹ã§ãããµã¡ã¿ãŸã³ããã1000å以äžæŽ»æ§ãå°
ããã ååç©ïŒ€ããåã³ïŒ§ã¯ãèžè ºã®éçž®ã®ç¹
ã§çŽ500ã1500å掻æ§ãå°ããã (2) ç®èäžã®æŽ»æ§ã®ç 究 ã¯ãæ²¹ã«ããåŒãèµ·ãããæ°Žè «ã®è©Šéš 䜿çšããæè¡ã¯ãTonelliæ°ä»ã®æè¡
ïŒEncocrinology1965ã77ã625ïŒã«ãã瀺åã
ãããã®ã§ãããæ°Žè «ã¯ããŠã¹ã®äžæ¹ã®è³ã«ã¯
ãæ²¹ãé©çšããããšã«ãã€ãŠåŒãèµ·ãããã (a) å±éšé©çšã«ããæŽ»æ§ ç¬¬äžã®ãããã®ããŠã¹ã«ã¯ãã¯ã油溶液ã
å³è³ã«é©çšããã 第äºã®ãããã®ããŠã¹ã«ã¯ãååç©ïŒ¡ã
ããããåã¯ïŒ§ãåã¯ãããµã¡ã¿
ãŸã³ãå ããã¯ã油溶液ãå³è³ã«é©çšããã ããŠã¹ã®å·Šè³ã«ã¯äœãé©çšããªãã ïŒæéåŸã«è³ãåé€ãã秀éãããå³è³ãš
å·Šè³ãšã®éã®ééå·®ãççã®åºŠåã瀺ãããš
ã«ãªãã çµæã¯ãAC50ãå³ã¡å¯Ÿç §äŸã«ãããŠã¯ã
æ²¹ã«ããåŒãèµ·ãããæ°Žè «ãååãŸã§æžå°ã
ãã掻æ§æ¿åºŠã«ãã€ãŠè¡šããããã
ãè¡šã
å±éšé©çšã«ããååç©ïŒ¡ãåã³ïŒ£ã®ç®è
äžã®æŽ»æ§ã¯ããããµã¡ã¿ãŸã³ã®ããã«å¹æµã
ãã å±éšé©çšã«ããååç©ïŒ€ããåã³ïŒ§ã®
ç®èäžã®æŽ»æ§ã¯ããããµã¡ã¿ãŸã³ã®ãããã
çŽïŒãïŒå匱ãã (b) çµå£æäžã«ããæŽ»æ§ åèšã®(a)ã®ããã«å®æœãããããã ãåå
ç©ïŒ¡ããåã³ãããµã¡ã¿ãŸã³ã¯ãæ°Žè «ã
ã¯ãæ²¹ã«ããåŒãèµ·ããããåæã«çµå£æäž
ããã AD50ãå³ã¡å¯Ÿç §äŸã«ãããæ°Žè «ãååãŸ
ã§æžå°ããã掻æ§è¬çšéãšããŠè¡šããããçµ
æã¯æ¬¡ã®éãã§ããã
äžã®æŽ»æ§ã¯ããããµã¡ã¿ãŸã³ã®ããã«å¹æµã
ãã å±éšé©çšã«ããååç©ïŒ€ããåã³ïŒ§ã®
ç®èäžã®æŽ»æ§ã¯ããããµã¡ã¿ãŸã³ã®ãããã
çŽïŒãïŒå匱ãã (b) çµå£æäžã«ããæŽ»æ§ åèšã®(a)ã®ããã«å®æœãããããã ãåå
ç©ïŒ¡ããåã³ãããµã¡ã¿ãŸã³ã¯ãæ°Žè «ã
ã¯ãæ²¹ã«ããåŒãèµ·ããããåæã«çµå£æäž
ããã AD50ãå³ã¡å¯Ÿç §äŸã«ãããæ°Žè «ãååãŸ
ã§æžå°ããã掻æ§è¬çšéãšããŠè¡šããããçµ
æã¯æ¬¡ã®éãã§ããã
ãè¡šã
ååç©ïŒ¡ãåã³ïŒ£ã®æŽ»æ§ã¯ããããµã¡ã¿
ãŸã³ã®ãããããå°ãªããšã360å匱ãã
ãŸã³ã®ãããããå°ãªããšã360å匱ãã
Claims (1)
- ãç¹èš±è«æ±ã®ç¯å²ã ïŒ æ¬¡åŒ ïŒããã§ïŒ¬ã¯æ°ŽçŽ ååãïŒã18åã®ççŽ ååãå«
æããã¢ã·ã«åºãã€ãœãã³ããã€ã«åºåã¯ãã³ã
ãã€ã«åºãè¡šããã 11βäœçœ®ã«ããã¯å¡©çŽ ååãè¡šããäžã€ïŒÎ±
äœçœ®ã«ããã¯å¡©çŽ åååã¯èçŽ ååãè¡šãã
ããæãã㯠11βäœçœ®ã«ããã¯ãµã€çŽ ååãè¡šããäžã€ïŒ
αäœçœ®ã«ããã¯å¡©çŽ ååãè¡šããïŒ ã®ååç©ã ïŒ ïŒ¬ãïŒã18åã®ççŽ ååãå«æããã¢ã·ã«åº
ãè¡šããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®åŒã®åå
ç©ã ïŒ ïŒ¬ãã¢ã»ãã«åºãè¡šããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒ
é èšèŒã®åŒã®ååç©ã ïŒ ïŒ¬ãããããã€ã«åºãã€ãœãã³ããã€ã«åºã
ãã«ãã«åºåã³ãã³ã¿ãã€ã«åºãããªã矀ããéž
ã°ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®åŒã®åå
ç©ã ïŒ ïŒ¹åã³ïŒžãäž¡è ãšãã«å¡©çŽ ååãè¡šããç¹èš±
è«æ±ã®ç¯å²ç¬¬ïŒãïŒåã¯ïŒé èšèŒã®åŒã®åå
ç©ã ïŒ ïŒ¹ãå¡©çŽ ååãè¡šããããèçŽ ååãè¡šã
ãç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒãïŒåã¯ïŒé èšèŒã®åŒã®
ååç©ã ïŒ ïŒ¹ããµã€çŽ ååãè¡šããããå¡©çŽ ååãè¡š
ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒãïŒåã¯ïŒé èšèŒã®åŒ
ã®ååç©ã ïŒ ïŒžåã³ïŒ¹ãäž¡è ãšãå¡©çŽ ååãè¡šããç¹èš±è«
æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®åŒã®ååç©ã ïŒ äžèšã®ååç© ïŒÎ±ã»11βâãžã¯ãã«â16αâã¡ãã«â21âã¢
ã»ããã·ãã¬ã°ãâïŒã»ïŒâãžãšã³âïŒã»20âãž
ãªã³ã ïŒÎ±âããã â11βâã¯ãã«â16αâã¡ãã«â
21âã¢ã»ããã·ãã¬ã°ãâïŒã»ïŒâãžãšã³âïŒã»
20âãžãªã³åã³ ïŒÎ±âã¯ãã«â11βâãã«ãªã«â16αâã¡ãã«
â21âã¢ã»ããã·ãã¬ã°ãâïŒã»ïŒâãžãšã³â
ïŒã»20âãžãªã³ ãããªã矀ããéžã°ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èš
èŒã®åŒã®ååç©ã ïŒïŒ äžèšã®ååç© ïŒÎ±ã»11βâãžã¯ãã«â16αâã¡ãã«â21âã
ãããã·ãã¬ã°ãâïŒã»ïŒâãžãšã³âïŒã»20âãž
ãªã³ã ïŒÎ±ã»11βâãžã¯ãã«â16αâã¡ãã«â21âã
ãããã€ã«ãªãã·ãã¬ã°ãâïŒã»ïŒâãžãšã³â
ïŒã»20âãžãªã³ã ïŒÎ±ã»11βâãžã¯ãã«â16αâã¡ãã«â21âã€
ãœãã³ããã€ã«ãªãã·ãã¬ã°ãâïŒã»ïŒâãžãšã³
âïŒã»20âãžãªã³ã ïŒÎ±ã»11βâãžã¯ãã«â16αâã¡ãã«â21âã
ã«ãã«ãªãã·ãã¬ã°ãâïŒã»ïŒâãžãšã³âïŒã»20
âãžãªã³åã³ ïŒÎ±ã»11βâãžã¯ãã«â16αâã¡ãã«â21âã
ã³ã¿ãã€ã«ãªãã·ãã¬ã°ãâïŒã»ïŒâãžãšã³â
ïŒã»20âãžãªã³ ãããªã矀ããéžã°ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èš
èŒã®ååç©ã ïŒïŒ æ¬¡åŒ ïŒããã§ïŒ¬ã¯æ°ŽçŽ ååãïŒã18åã®ççŽ ååãå«
æããã¢ã·ã«åºãã€ãœãã³ããã€ã«åºåã¯ãã³ã
ãã€ã«åºãè¡šããã 11βäœçœ®ã«ããã¯å¡©çŽ ååãè¡šããäžã€ïŒÎ±
äœçœ®ã«ããã¯å¡©çŽ åååã¯èçŽ ååãè¡šãã
ããæãã㯠11βäœçœ®ã«ããã¯ãµã€çŽ ååãè¡šããäžã€ïŒ
αäœçœ®ã«ããã¯å¡©çŽ ååãè¡šããïŒ ã®ååç©ã補é ããã«ããããæ¬¡åŒ ïŒããã§ïŒ¬ã¯åèšã®æå³ãæããïŒ ã®ååç©ã«ãïŒÎ±ã®ããã²ã³åååã³11βã®å¥
ã®ããã²ã³ååïŒïŒžåã³ïŒ¹ã¯åèšã®æå³ãæã
ãïŒãå°å ¥ã§ããããã²ã³åå€ãäœçšãããŠå¯Ÿå¿
ããåŒã®ååç©ãåŸãããšãç¹åŸŽãšããåèšåŒ
ã®ååç©ã®è£œé æ³ã ïŒïŒ ããã²ã³åå€ãâã¹ã¯ã·ã³ã€ããåã¯
âã¢ã»ãã¢ãããšããã²ã³åç©ã€ãªã³Y-ã
äžããè©Šå€ãšã®æ··åç©ïŒïŒžåã³ïŒ¹ã¯åèšãšåãæ
å³ãæããïŒãããªãããšãç¹åŸŽãšããç¹èš±è«æ±
ã®ç¯å²ç¬¬ïŒïŒé èšèŒã®æ¹æ³ã ïŒïŒ æ¬¡åŒ ïŒããã§ïŒ¬ã¯æ°ŽçŽ ååãïŒã18åã®ççŽ ååãå«
æããã¢ã·ã«åºãã€ãœãã³ããã€ã«åºåã¯ãã³ã
ãã€ã«åºãè¡šããã 11βäœçœ®ã«ããã¯å¡©çŽ ååãè¡šããäžã€ïŒÎ±
äœçœ®ã«ããã¯å¡©çŽ åååã¯èçŽ ååãè¡šãã
ããæãã㯠11βäœçœ®ã«ããã¯ãµã€çŽ ååãè¡šããäžã€ïŒ
αäœçœ®ã«ããã¯å¡©çŽ ååãè¡šããïŒ ã®ååç©ã®å°ãªããšãïŒçš®ãå«æããæççå€çµ
æç©ã
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7605854A FR2342738A1 (fr) | 1976-03-02 | 1976-03-02 | Nouveaux derives halogenes de la serie du 16a-methyl pregnane |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS52106855A JPS52106855A (en) | 1977-09-07 |
JPS6150960B2 true JPS6150960B2 (ja) | 1986-11-06 |
Family
ID=9169832
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2039977A Granted JPS52106855A (en) | 1976-03-02 | 1977-02-28 | Novel halogenated derivatives of 16 alphaamethypregnane * preparation thereof and pharmaceutical composition |
Country Status (16)
Country | Link |
---|---|
JP (1) | JPS52106855A (ja) |
AT (1) | AT355237B (ja) |
AU (1) | AU509948B2 (ja) |
BE (1) | BE851944A (ja) |
CA (1) | CA1082170A (ja) |
CH (1) | CH619969A5 (ja) |
DE (1) | DE2709078C2 (ja) |
DK (1) | DK156401C (ja) |
FR (1) | FR2342738A1 (ja) |
GB (1) | GB1530975A (ja) |
IE (1) | IE44866B1 (ja) |
LU (1) | LU76867A1 (ja) |
NL (1) | NL7702166A (ja) |
PT (1) | PT66261B (ja) |
SE (1) | SE7702250L (ja) |
ZA (1) | ZA771078B (ja) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2462443A1 (fr) * | 1979-07-26 | 1981-02-13 | Roussel Uclaf | Nouveau derive halogene de la serie du 16a-methyl pregnane, son procede de preparation et son application comme medicament |
FR2533928A1 (fr) * | 1982-10-05 | 1984-04-06 | Roussel Uclaf | Nouveaux derives dichlores de la serie du 16a-methyl pregnane, leur procede de preparation et leur application comme medicaments |
DE4433374A1 (de) * | 1994-09-20 | 1996-03-21 | Hoechst Ag | 17-Desoxi-corticosteroid-21-/O/-CarbonsÀure- ester, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB928301A (en) * | 1958-06-20 | 1963-06-12 | Scherico Ltd | 9, 11-dihalogeno steroids |
US3049554A (en) * | 1959-06-01 | 1962-08-14 | Schering Corp | 9, 11-dihalogeno-3, 20-diketopregnanes and processes for their manufacture |
-
1976
- 1976-03-02 FR FR7605854A patent/FR2342738A1/fr active Granted
-
1977
- 1977-02-23 ZA ZA00771078A patent/ZA771078B/xx unknown
- 1977-02-28 JP JP2039977A patent/JPS52106855A/ja active Granted
- 1977-03-01 DK DK088277A patent/DK156401C/da not_active IP Right Cessation
- 1977-03-01 LU LU76867A patent/LU76867A1/xx unknown
- 1977-03-01 NL NL7702166A patent/NL7702166A/xx not_active Application Discontinuation
- 1977-03-01 AU AU22808/77A patent/AU509948B2/en not_active Expired
- 1977-03-01 BE BE175355A patent/BE851944A/xx not_active IP Right Cessation
- 1977-03-01 AT AT136577A patent/AT355237B/de not_active IP Right Cessation
- 1977-03-01 CA CA272,894A patent/CA1082170A/fr not_active Expired
- 1977-03-01 SE SE7702250A patent/SE7702250L/ not_active Application Discontinuation
- 1977-03-02 PT PT66261A patent/PT66261B/pt unknown
- 1977-03-02 DE DE2709078A patent/DE2709078C2/de not_active Expired
- 1977-03-02 GB GB8713/77A patent/GB1530975A/en not_active Expired
- 1977-03-02 CH CH264177A patent/CH619969A5/fr not_active IP Right Cessation
- 1977-03-02 IE IE462/77A patent/IE44866B1/en unknown
Also Published As
Publication number | Publication date |
---|---|
ATA136577A (de) | 1979-07-15 |
IE44866L (en) | 1977-09-02 |
AU509948B2 (en) | 1980-06-05 |
DK88277A (da) | 1977-09-03 |
AU2280877A (en) | 1978-09-07 |
PT66261B (fr) | 1979-01-17 |
DK156401B (da) | 1989-08-14 |
BE851944A (fr) | 1977-09-01 |
PT66261A (fr) | 1977-04-01 |
SE7702250L (sv) | 1977-09-03 |
DE2709078A1 (de) | 1977-09-08 |
CA1082170A (fr) | 1980-07-22 |
IE44866B1 (en) | 1982-04-21 |
DE2709078C2 (de) | 1986-09-11 |
DK156401C (da) | 1990-01-08 |
JPS52106855A (en) | 1977-09-07 |
AT355237B (de) | 1980-02-25 |
FR2342738A1 (fr) | 1977-09-30 |
GB1530975A (en) | 1978-11-01 |
ZA771078B (en) | 1978-04-26 |
LU76867A1 (ja) | 1977-09-26 |
NL7702166A (nl) | 1977-09-06 |
FR2342738B1 (ja) | 1979-10-12 |
CH619969A5 (en) | 1980-10-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA1134345A (en) | Thio etianic acid derivatives | |
CA1234564A (en) | Carboxylic acid esters | |
US4172132A (en) | 1,3,5(10),6,8,14-19-Nor-pregnahexaenes, their use as anti-psoriatic agents, and pharmaceutical formulations useful therefor | |
US4576936A (en) | 6α-Fluoro-9α-chloro-prednisolone 17,21-diesters | |
US3984544A (en) | Retinoic acid esters of steroids of the pregnane series, their use in the treatment of acne and pharmaceutical formulations useful therefor | |
US4645763A (en) | 6α-methyl corticoids, their production and use | |
US4024131A (en) | 16-Methyl-9α-halo steroid esters, ethers and preparation thereof | |
KR930009445B1 (ko) | ì ê· ì€í ë¡ìŽë ëì¬ê³Œ ìŽë€ì íšì íë ìœì íì ì¡°ì±ë¬Œ ë° ìŽë€ì ì ì¡°ë°©ë² | |
CA1251784A (en) | Steroids esterified in position 17 and thioesterified in position 21, a process for preparing them and their use as medicaments | |
JPS6150960B2 (ja) | ||
JPS5837320B2 (ja) | ãã¬ã°ãã³ãµã³ãŠãŠããŠã¿ã€ ã ã»ã€ã㊠| |
JPS6214557B2 (ja) | ||
JPS6044320B2 (ja) | ã¹ããã€ãæ§ïŒïŒïŒïŒÎ²âãžããâãïŒïŒÎ±ïŒïŒïŒâïœããïŒïŒïŒããžãªããµã³é¡ã®è£œé æ³ | |
JPS636559B2 (ja) | ||
US4261986A (en) | 4-Halo etianic acids and derivatives thereof | |
CA1141751A (fr) | PROCEDE DE PREPARATION D'UN NOUVEAU DERIVE HALOGENE DE LA SERIE DU 16.alpha.-METHYL PREGNANE | |
JPS6249280B2 (ja) | ||
US3763196A (en) | 17-esters of 6alpha-9alpha-difluoro-21-desoxyprednisolone | |
KR800000407B1 (ko) | D-ížëªšì€í ë¡ìŽëì ì ì¡°ë°©ë² | |
CS202591B2 (en) | Process for preparing derivatives of 9-fluorprednisolone | |
CA1078824A (en) | Halogenopregnadienes and process for the manufacture thereof | |
EP0000609A1 (en) | Novel 19-nor-pregnahexaenes, process for the preparation thereof, and pharmaceutical compositions containing them | |
JPH0125759B2 (ja) | ||
JPS604198B2 (ja) | ïŒïŒïŒïŒâãžãªããœâïŒÎ±âããâïŒâãã¬ã°ãã³é¡ãŸãã¯âïŒïŒïŒâãã¬ã°ããžãšã³é¡ãããã³ãã®è£œé æ¹æ³ãªãã³ã«è©²ååç©ãå«æããæççå€ | |
CS207755B2 (cs) | Způsob vÃœroby v poloze 17 substituovanÃœch 11áµ-hydroxysteroidů pregnanové Åady |